Soc. Generale Call 38 FPE3 20.09..../ DE000SU74W25 /
2024-05-29 12:36:53 PM | Chg.-0.050 | Bid1:07:45 PM | Ask1:07:45 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.730EUR | -6.41% | 0.730 Bid Size: 5,000 |
0.740 Ask Size: 5,000 |
FUCHS SE VZO NA O.N... | 38.00 EUR | 2024-09-20 | Call |
GlobeNewswire
1:02 PM
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
1:00 PM
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire
1:00 PM
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire
1:00 PM
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
1:00 PM
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire
1:00 PM
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire
1:00 PM
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire
1:00 PM
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire
1:00 PM
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire
1:00 PM
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024